Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours

410Citations
Citations of this article
462Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The PI3 K/AKT/mTOR signalling pathway plays an important role in the regulation of signal transduction and biological processes such as cell proliferation, apoptosis, metabolism and angiogenesis. Compared with those of other signalling pathways, the components of the PI3K/AKT/mTOR signalling pathway are complicated. The regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway are important in many human diseases, including ischaemic brain injury, neurodegenerative diseases, and tumours. PI3K/AKT/mTOR signalling pathway inhibitors include single-component and dual inhibitors. Numerous PI3K inhibitors have exhibited good results in preclinical studies, and some have been clinically tested in haematologic malignancies and solid tumours. In this review, we briefly summarize the results of research on the PI3K/AKT/mTOR pathway and discuss the structural composition, activation, communication processes, regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway in the pathogenesis of neurodegenerative diseases and tumours.

Cite

CITATION STYLE

APA

Xu, F., Na, L., Li, Y., & Chen, L. (2020, April 1). Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell and Bioscience. BioMed Central Ltd. https://doi.org/10.1186/s13578-020-00416-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free